Perspective Therapeutics (CATX) Goodwill (2023 - 2024)
Perspective Therapeutics (CATX) reported Goodwill of $24.1 million for Q3 2024, down 11.78% on a YoY basis from $27.3 million in Q4 2023, and little changed sequentially from $24.1 million in Q2 2024.
Perspective Therapeutics (CATX) Goodwill (2023 - 2024) Analysis & Trends
Perspective Therapeutics (CATX) has 2 years of Goodwill data on file, last reported at $24.1 million in Q3 2024.
- For the quarter ending Q3 2024, Goodwill fell 11.78% year-over-year to $24.1 million; the trailing twelve-month figure through Sep 2024 stood at $24.1 million (down 11.78% YoY), and the FY2023 full-year result was $24.1 million, changed N/A from the prior year.
- Goodwill was little changed at $24.1 million in Q3 2024, from $24.1 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $27.3 million in Q2 2023 to a low of $24.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Perspective Therapeutics | 294.24 Mn | 294.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 24.10 Mn |
| Jun 30, 2024 | 24.10 Mn |
| Mar 31, 2024 | 24.06 Mn |
| Dec 31, 2023 | 24.10 Mn |
| Sep 30, 2023 | 27.32 Mn |
| Jun 30, 2023 | 27.32 Mn |
| Mar 31, 2023 | 27.30 Mn |